Anzeige
❌
Mehr »
Dienstag, 17.11.2026 - Börsentäglich über 12.000 News
Milliardenmarkt Quantensicherheit! Ist diese Aktie noch völlig unterschätzt?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von BioPharma Dive

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
18:46Roche breast cancer pill cleared by FDA
17:46AI drugmaker Isomorphic restocks with $5B fundraise
13:46Marrow sets out to challenge genetic medicines for severe blood diseases
MoSummit shares fall as FDA rejects closely watched PD-1/VEGF drug
MoJ&J bets $2.2B on Ollin's vision loss drug
MoLilly adds to buyout streak with $1.5B purchase of startup Calytrix
MoBig-name investors pour $100M into DNA therapeutics developer Seawolf
MoCompleting the circle: the next evolution in sustainable pharmaceutical blister packaging
MoYour AI pilots aren't stalling because of the AI - they're stalling because of your environment
MoThe infrastructure decisions that will enable tomorrow's biggest breakthroughs
MoOne of Europe's leading VCs banks a €725M 'crossover' fund
FrNovo submits sickle cell drug; Flagship, Gates Foundation deepen ties
FrThis week in charts: Brain drugs are back on venture capitalists' minds
FrWindward prices $175M IPO to advance China-licensed lung drugs
DoBlackstone bets $1.5B on Pfizer's obesity drug
DoBristol Myers research chief to depart in 'evolution' of company's structure
DoThe FDA has over 1k open jobs - and the staffing shortage is hitting pharma
MiDrug price hikes in Germany could push US costs higher, study says
MiAstraZeneca buys vaccine startup; FDA issues GLP-1 safety warning
10.11.PepGen soars on promising early data for muscular dystrophy drug
10.11.Beam's base editing therapy for sickle cell hits goal in pivotal trial
10.11.London biotech Oyster harvests $60M for tau-targeting brain drugs
09.11.Bayer wins FDA nod for a new kind of blood thinner
09.11.Vir hepatitis D drug succeeds in first pivotal study
09.11.Argenx to buy peptide platform in potentially billion-dollar deal